AR032619A1 - Compuestos de dihidropiridina, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la manufactura de medicamentos y procesos para preparar dichos compuestos - Google Patents
Compuestos de dihidropiridina, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la manufactura de medicamentos y procesos para preparar dichos compuestosInfo
- Publication number
- AR032619A1 AR032619A1 ARP010102565A ARP010102565A AR032619A1 AR 032619 A1 AR032619 A1 AR 032619A1 AR P010102565 A ARP010102565 A AR P010102565A AR P010102565 A ARP010102565 A AR P010102565A AR 032619 A1 AR032619 A1 AR 032619A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- aryl
- compounds
- substituted
- amino
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 239000003814 drug Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 8
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 150000005676 cyclic carbonates Chemical class 0.000 abstract 3
- 125000004925 dihydropyridyl group Chemical class N1(CC=CC=C1)* 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical group O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 208000026935 allergic disease Diseases 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 150000002596 lactones Chemical class 0.000 abstract 2
- 230000009885 systemic effect Effects 0.000 abstract 2
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 abstract 1
- 208000009079 Bronchial Spasm Diseases 0.000 abstract 1
- 208000014181 Bronchial disease Diseases 0.000 abstract 1
- 206010006482 Bronchospasm Diseases 0.000 abstract 1
- 229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical group NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000005872 Diffuse Esophageal Spasm Diseases 0.000 abstract 1
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 208000017228 Gastrointestinal motility disease Diseases 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 206010030184 Oesophageal spasm Diseases 0.000 abstract 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 abstract 1
- 206010036600 Premature labour Diseases 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 208000026723 Urinary tract disease Diseases 0.000 abstract 1
- 150000003973 alkyl amines Chemical class 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 150000001408 amides Chemical group 0.000 abstract 1
- -1 amino, dimethylamino Chemical group 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 230000003361 anti-bronchoconstrictory effect Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 150000004649 carbonic acid derivatives Chemical group 0.000 abstract 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical group [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003107 drug analog Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000009610 hypersensitivity Effects 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 208000026440 premature labor Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 208000014001 urinary system disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Compuestos de dihidropiridina de Formula (1) o sus sales farmacéuticamente aceptables, en donde (a) Ö es una porcion que contiene anillo de dihidropiridina, porcion que está unida al carbono de carbonilo de Formula (1) por medio de un átomo de carbono en la posicion meta con respecto al átomo de nitrogeno del anillo de piridina; y (b) R1 se selecciona entre el grupo que consiste en ûalquil-OH, alquilamina, lactona, carbonato cíclico, carbonato cíclico sustituido con alquilo, carbonato cíclico sustituido con arilo, -aril-C(O)OR', -alquil-aril-C(O)OR', -alquil-OC(O)R', -alquil-C(O)R', -alquil-C(O)OR', -alquil-N(R'')C(O)R' y ûalquil-N(R'')C(O)OR', en donde R' y R'' se seleccionan independientemente entre el grupo que consiste en hidrogeno, amino, alquilo, arilo, cicloalquilo fusionado con arilo y heterociclilo, siendo el amino, alquilo, arilo, cicloalquilo fusionado con arilo y heterociclilo sustituido optativamente con halogeno, ciano, NO2, lactona , amino, alquilamino, alquilamino sustituido con arilo, amida, carbamato, carbamoílo, carbonato cíclico, alquilo, alquilo sustituido con halogeno, arilalquilo, alcoxi, heterociclilo y/o arilo (el arilo siendo optativamente sustituido con OH, halogeno, ciano, NO2, alquilo, amino, dimetilamino, alcoxi, alquilsulfonilo, carboalcoxi C1-4, alquiltio y/o trifluorometilo). Estos compuestos son drogas blandas de dihidropiridina, es decir, son drogas biologicamente activas que son metabolicamente inactivadas después de que logran su rol terapéutico en su sitio de accion designado. Estos compuestos son utiles como antagonistas de los canales del calcio con actividad cardiovascular, antiasmática y antibroncoconstrictora. El uso de tales análogos de drogas blandas permite la administracion de mayores dosis de los compuestos de dihidropiridina reivindicados sin efectos sistémicos intolerables. Por consiguiente se los utiliza para evitar y tratar trastornos como ser hipersensibilidad, alergia, asma, broncoespasmo, dismenorrea, espasmo esofágico, glaucoma, trabajo de parto prematuro, trastornos del tracto urinario, trastornos de la motilidad gastrointestinal y trastornos cardiovasculares, evitando efectos sistémicos indeseados. Además, se dan a conocer: composiciones farmacéuticas que los comprenden, el uso de dichos compuestos en la manufactura de medicamentos y procesos para preparar dichos compuestos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20791500P | 2000-05-30 | 2000-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR032619A1 true AR032619A1 (es) | 2003-11-19 |
Family
ID=22772486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010102565A AR032619A1 (es) | 2000-05-30 | 2001-05-29 | Compuestos de dihidropiridina, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la manufactura de medicamentos y procesos para preparar dichos compuestos |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6562824B2 (es) |
| EP (1) | EP1296990A2 (es) |
| JP (1) | JP2003535096A (es) |
| CN (2) | CN1444587A (es) |
| AR (1) | AR032619A1 (es) |
| AU (1) | AU2001261161A1 (es) |
| CA (1) | CA2410655A1 (es) |
| WO (1) | WO2001092267A2 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201007251A2 (tr) | 2010-09-01 | 2012-03-21 | Bi̇lgi̇ç Mahmut | Kalsiyum kanal blokörü formülasyonu. |
| AU2017205254B2 (en) * | 2016-01-04 | 2021-05-20 | Xoma (Us) Lcc | Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4285955A (en) | 1978-10-31 | 1981-08-25 | Bayer Aktiengesellschaft | 1,4-Dihydropyridinecarboxylic acids |
| US4483985A (en) | 1978-10-31 | 1984-11-20 | Bayer Aktiengesellschaft | Production of 1,4-dihydropyridinecarboxylic acids |
| NZ201395A (en) | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| JPS58201764A (ja) | 1982-05-17 | 1983-11-24 | Maruko Seiyaku Kk | ジヒドロピリジン誘導体 |
| US4845225A (en) | 1986-04-09 | 1989-07-04 | Ortho Pharmaceutical Corporation | Substituted thiacycloalkeno [3,2-b] pyridines |
| US4879384A (en) * | 1988-06-15 | 1989-11-07 | Ortho Pharmaceutical Corporation | Preparation of thiocycloalkno [3,2-b] pyridines |
| US5075440A (en) | 1990-05-03 | 1991-12-24 | Ortho Pharmaceutical Corporation | Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines |
| EP0639986A1 (en) * | 1992-05-13 | 1995-03-01 | Alcon Laboratories, Inc. | Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
| US5922773A (en) * | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
| US6017965A (en) | 1993-02-08 | 2000-01-25 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| DE19532320A1 (de) | 1995-09-01 | 1997-03-06 | Bayer Ag | Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen |
| AU9040098A (en) | 1997-09-10 | 1999-03-29 | University Of Florida | Compounds and method for the prevention and treatment of diabetic retinopathy |
-
2001
- 2001-05-02 CN CN01813468A patent/CN1444587A/zh active Pending
- 2001-05-02 CA CA002410655A patent/CA2410655A1/en not_active Abandoned
- 2001-05-02 WO PCT/US2001/014309 patent/WO2001092267A2/en not_active Ceased
- 2001-05-02 AU AU2001261161A patent/AU2001261161A1/en not_active Abandoned
- 2001-05-02 US US09/847,228 patent/US6562824B2/en not_active Expired - Lifetime
- 2001-05-02 EP EP01935032A patent/EP1296990A2/en not_active Withdrawn
- 2001-05-02 JP JP2002500880A patent/JP2003535096A/ja active Pending
- 2001-05-02 CN CNA2005100637580A patent/CN1680324A/zh active Pending
- 2001-05-29 AR ARP010102565A patent/AR032619A1/es not_active Application Discontinuation
-
2003
- 2003-03-19 US US10/392,038 patent/US20030225120A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001092267A2 (en) | 2001-12-06 |
| AU2001261161A1 (en) | 2001-12-11 |
| WO2001092267A3 (en) | 2002-06-27 |
| CA2410655A1 (en) | 2001-12-06 |
| CN1680324A (zh) | 2005-10-12 |
| US20030225120A1 (en) | 2003-12-04 |
| CN1444587A (zh) | 2003-09-24 |
| JP2003535096A (ja) | 2003-11-25 |
| US20020133018A1 (en) | 2002-09-19 |
| EP1296990A2 (en) | 2003-04-02 |
| US6562824B2 (en) | 2003-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2567197T3 (es) | Derivado de carbamoilpiridona policíclico que tiene actividad inhibidora de la integrasa del VIH | |
| ES2270840T3 (es) | Imidazoquinolinas sustituidas con sulfonamida y sulfamida. | |
| EP0923570B1 (en) | Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives | |
| ES2940911T3 (es) | Compuestos de 2,4-diamino-pirimidina y su uso como inhibidores de IRAK4 | |
| EP0934309B1 (en) | New pyridyl alkane acid amides as cytostatics and immunosuppressives | |
| ES2291642T3 (es) | Hidroxinaftiridinoncarboxamidas utiles como inhibidores de la integrasa de vih. | |
| AU2020341708B2 (en) | RIP1 inhibitory compounds and methods for making and using the same | |
| RU99101069A (ru) | Амиды пиридилалкеновых и пиридилалкиновых кислот в качестве цитостатиков и иммуносупрессорных агентов | |
| AU2023266279B2 (en) | Tetracyclic compounds for treating HIV infection | |
| ES2987436T3 (es) | Conjugado de polímero para la administración de un agente bioactivo | |
| ES2436109T3 (es) | Conjugados poliméricos de múltiples brazos de 7-etil-10-hidroxicamptotecina para el tratamiento del cáncer de mama, del cáncer colorrectal, del cáncer de páncreas, de ovario y de pulmón | |
| AR035518A1 (es) | Derivados de carboxamida, un procedimiento para su preparacion, un medicamento que los contiene, el u so de los mismos para preparar un medicamento, y un conjunto (kit) que los incluye | |
| AR050184A1 (es) | Inhibidores macrociclicos de beta-secretasa | |
| AR035517A1 (es) | Derivados de piperazina, proceso para prepararlos, composiciones farmaceuticas que los comprenden, y uso de dichos compuestos en la elaboracion de medicamentos | |
| AR044045A1 (es) | Compuesto de piperidincarbonilpiperazina, composicion farmaceutica que lo comprende, su uso para la elaboracion de un medicamento y procedimiento para su preparacion | |
| CY1112601T1 (el) | Υποκατεστημενα παραγωγα 1-πιπεριδιν-4-υλ-4-πυρρολιδιν-3-υλ-πιπεραζινης και χρηση αυτων ως ανταγωνιστων νευροκινινης | |
| NO172580C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte n-(1-alkyl-3-hydroksy-4-piperidinyl)benzamider | |
| AR051391A1 (es) | Compuesto de pirrolidina antagonista del receptor h3; composicion farmaceutica que lo comprende, su uso para preparar un medicamento para el tratamiento de enfermedades neurologicas y un procedimiento para su elaboracion. | |
| EA200801909A1 (ru) | Соединения пиридина для лечения заболеваний, опосредованных действием простагландина | |
| AR035945A1 (es) | Derivados de piperacina, su uso en la preparacion de medicamentos, procedimiento para la preparacion de dichos compuestos, composiciones farmaceuticas que comprenden dichos compuestos, y metodo para preparar dichas composiciones | |
| WO2001072710A1 (en) | Heterocycle derivatives and drugs | |
| TW201134820A (en) | Arylsulfonamide CCR3 antagonists | |
| JP2016065062A (ja) | 治療特性を有する１，４−ベンゾジアゼピン−２，５−ジオンおよび関連化合物 | |
| AR032475A1 (es) | Un compuesto derivado de quinazolina, su uso, procedimiento para prepararlo, y una composicion farmaceutica que lo comprende | |
| AR032619A1 (es) | Compuestos de dihidropiridina, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la manufactura de medicamentos y procesos para preparar dichos compuestos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |